Alpha 2.0
Login Register
» Articles » PMID: 6115665

Beta-adrenoceptor Blockers and the Blood-brian Barrier

Overview
Journal Br J Clin Pharmacol
Specialty Pharmacology
Date 1981 Jun 1
PMID 6115665
Citations 66
Authors
G Neil-Dwyer
J Bartlett
J Mcainsh
J M Cruickshank
Affiliations
Soon will be listed here.
Abstract

1 This study on 21 neurosurgical patients was set up to investigate the extent to which four chronically administered beta-adrenoceptor blockers, propranolol, oxprenolol, metoprolol and atenolol, cross and blood-brain barrier and enter the cerebrospinal fluid (CSF) and brain tissue. The concentration in the CSF of the three lipophilic beta-adrenoceptor blockers, propranolol, oxprenolol and metoprolol, approximated to the free drug concentration in the plasma, and was a poor predictor of brain concentration. These three lipophilic beta-adrenoceptor blockers appeared in brain tissue at concentrations 10-20 times greater than that of hydrophilic atenolol. The approximate brain/plasma ratio for propranolol was 26, for oxprenolol 50, for metoprolol 12 and for atenolol 0.2. 2 The low concentration of atenolol in brain tissue is possibly responsible for the low incidence of central nervous system-related side effects in patients on this agent compared to lipophilic beta-adrenoceptor blockers.

Citing Articles

Propranolol As an Anxiolytic to Reduce the Use of Sedatives for Critically Ill Adults Receiving Mechanical Ventilation (PROACTIVE): An Open-Label Randomized Controlled Trial.

Downar J, Lapenskie J, Kanji S, Watpool I, Haines J, Saeed U Crit Care Med. 2025; 53(2):e257-e268.

PMID: 39982178 PMC: 11801419. DOI: 10.1097/CCM.0000000000006534.

Propranolol Effective in Suppressing Paroxysmal Sympathetic Hyperactivity Attacks Occurring in the Acute Phase of Diffuse Axonal Injury: A Case Report.

Shinoda S, Tanei T, Nakanishi H, Saito R Cureus. 2025; 17(1):e77653.

PMID: 39968423 PMC: 11834331. DOI: 10.7759/cureus.77653.

Systemic and cerebro-cardiac biomarkers following traumatic brain injury: an interim analysis of randomized controlled clinical trial of early administration of beta blockers.

El-Menyar A, Asim M, Khan N, Rizoli S, Mahmood I, Al-Ani M Sci Rep. 2024; 14(1):19574.

PMID: 39179700 PMC: 11343837. DOI: 10.1038/s41598-024-70470-y.

Prevalence of cardiovascular drug-related adverse drug reactions consultations in UK primary care: A cross-sectional study.

Insani W, Whittlesea C, Wei L PLoS One. 2024; 19(7):e0307237.

PMID: 39046945 PMC: 11268649. DOI: 10.1371/journal.pone.0307237.

Preclinical Studies on Mechanisms Underlying the Protective Effects of Propranolol in Traumatic Brain Injury: A Systematic Review.

Jae J, Li Y, Sun C, Allan A, Basmaji J, Chilton S J Neuroimmune Pharmacol. 2024; 19(1):33.

PMID: 38900343 DOI: 10.1007/s11481-024-10121-1.

References
1.
Myers M, Lewis P, Reid J, Dollery C . Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther. 1975; 192(2):327-35. View
2.
SCALES B, Copsey P . The gas chromatographic determination of atenolol in biological samples. J Pharm Pharmacol. 1975; 27(6):430-3. DOI: 10.1111/j.2042-7158.1975.tb09473.x. View
3.
Fraser H, Carr A . Propranolol psychosis. Br J Psychiatry. 1976; 129:508-9. DOI: 10.1192/bjp.129.5.508b. View
4.
van Zwieten P, Timmermans P . Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol. J Cardiovasc Pharmacol. 1979; 1(1):85-96. DOI: 10.1097/00005344-197901000-00009. View
5.
Neil-Dwyer G, Walter P, Cruickshank J, Doshi B, OGorman P . Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J. 1978; 2(6143):990-2. PMC: 1607890. DOI: 10.1136/bmj.2.6143.990. View